Literature DB >> 18467928

Comparison of disability and quality of life measures in patients with long-term psychotic disorders and patients with multiple sclerosis: an application of the WHO Disability Assessment Schedule II and WHO Quality of Life-BREF.

Prem Chopra1, Helen Herrman, Genevieve Kennedy.   

Abstract

The aim of this article is to compare the applications of the WHO Disability Assessment Schedule II (WHODAS II) and WHO Quality of Life-BREF (WHOQOL-BREF) in the assessment of patients with psychotic disorders and multiple sclerosis, and to assess the feasibility and usefulness of such universal measures in the psychiatric as well as physical rehabilitation setting. Twenty patients with psychotic disorders from St Vincent's Mental Health Service and 20 patients from the Medical Rehabilitation Ward of St Vincent's Hospital were assessed. The WHODAS II and WHOQOL-BREF were administered to each patient to obtain their perception of the impact of their disability and their health-related quality of life (HRQoL). The WHODAS II and WHOQOL-BREF interviews were meaningful as they highlighted aspects of patients' disabilities as well as issues that led to impairment in HRQoL. The WHODAS II and WHOQOL-BREF total scores were higher overall for patients with multiple sclerosis, reflecting, in particular, the physical impact of this condition. Patients with psychotic disorders generally did not report difficulty in self-care. Both patients with multiple sclerosis and patients with psychotic disorders reported similar levels of difficulty in the domain of participation in society. Universal measures of disability and HRQoL are feasible for use in patients with long-term physical and psychiatric illnesses. Similarities in the disability profiles of patients in the two groups reflect the consequences of the long-term conditions under investigation. Both groups of patients reported similar levels of social disability, confirming that barriers to participation in society affect all patients with disabling conditions.

Entities:  

Mesh:

Year:  2008        PMID: 18467928     DOI: 10.1097/MRR.0b013e32830150e6

Source DB:  PubMed          Journal:  Int J Rehabil Res        ISSN: 0342-5282            Impact factor:   1.479


  12 in total

Review 1.  Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice.

Authors:  Deborah M Miller; Rebecca Allen
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

2.  Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.

Authors:  Kirsty Winkley; Rebecca Upsher; Daniel Stahl; Daniel Pollard; Architaa Kasera; Alan Brennan; Simon Heller; Khalida Ismail
Journal:  Health Technol Assess       Date:  2020-06       Impact factor: 4.014

3.  The cultural adaptability of intermediate measures of functional outcome in schizophrenia.

Authors:  Dawn I Velligan; Maureen Rubin; Megan M Fredrick; Jim Mintz; Keith H Nuechterlein; Nina R Schooler; Judith Jaeger; Nancy M Peters; Raimund Buller; Stephen R Marder; Sanjay Dube
Journal:  Schizophr Bull       Date:  2010-12-06       Impact factor: 9.306

4.  Validity and Reliability of the Turkish Version of the Monitoring My Multiple Sclerosis Scale.

Authors:  Cansu Polat; Zeliha Tülek; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2017-01-19       Impact factor: 1.339

5.  Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis.

Authors:  Deborah M Miller; Francois Bethoux; David Victorson; Cindy J Nowinski; Sarah Buono; Jin-Shei Lai; Katy Wortman; James L Burns; Claudia Moy; David Cella
Journal:  Mult Scler       Date:  2015-08-03       Impact factor: 6.312

6.  The association between psychotic experiences and disability: results from the WHO World Mental Health Surveys.

Authors:  F Navarro-Mateu; J Alonso; C C W Lim; S Saha; S Aguilar-Gaxiola; A Al-Hamzawi; L H Andrade; E J Bromet; R Bruffaerts; S Chatterji; L Degenhardt; G de Girolamo; P de Jonge; J Fayyad; S Florescu; O Gureje; J M Haro; C Hu; E G Karam; V Kovess-Masfety; S Lee; M E Medina-Mora; A Ojagbemi; B-E Pennell; M Piazza; J Posada-Villa; K M Scott; J C Stagnaro; M Xavier; K S Kendler; R C Kessler; J J McGrath
Journal:  Acta Psychiatr Scand       Date:  2017-05-25       Impact factor: 6.392

7.  Development of the Global Disability Scale (Glo.Di.S): preliminary results.

Authors:  Konstantinos N Fountoulakis; Eirini Lekka; Evangelia Kouidi; Ioanna Chouvarda; Asterios Deligiannis; Nickolaos Maglaveras
Journal:  Ann Gen Psychiatry       Date:  2012-05-17       Impact factor: 3.455

8.  Exploring factors relevant in the assessment of the return-to-work process of employees on long-term sickness absence due to a depressive disorder: a focus group study.

Authors:  Anna Muijzer; Sandra Brouwer; Jan H Geertzen; Johan W Groothoff
Journal:  BMC Public Health       Date:  2012-02-06       Impact factor: 3.295

9.  Domains and determinants of quality of life in schizophrenia and systemic lupus erythematosus.

Authors:  Rajiv Radhakrishnan; Jayakumar Menon; Milanduth Kanigere; Mysore Ashok; Vineeta Shobha; R B Galgali
Journal:  Indian J Psychol Med       Date:  2012-01

10.  Assessing clinical correlates of self-rated disability in patients with multiple sclerosis.

Authors:  Giuseppe Magistrale; Rossella Medori; Diego Cadavid; Ornella Argento; Chiara Incerti; Valerio Pisani; Carlo Caltagirone; Marco Bozzali; John DeLuca; Ugo Nocentini
Journal:  Mult Scler J Exp Transl Clin       Date:  2015-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.